Keyphrases
Accelerated Approval
22%
Antineoplastic Agents
5%
BRAFV600
11%
Cancer Clinical Trials
13%
Clinical Drug Trials
5%
Clinical Trial Registry
23%
Clinical Trials
66%
Company Website
5%
Core Outcome Set
33%
Cost-plus
33%
Cuban
33%
Dabrafenib
33%
Dabrafenib Plus Trametinib
5%
Data Extraction
9%
Data Screening
9%
Drug Companies
33%
Drug Development
38%
Health Care Costs
11%
Health Research
19%
Improved Outcomes
9%
Instructions to Authors
9%
Kinase Inhibitor
5%
Malignancy
11%
Medicaid
33%
Medicaid Spending
5%
Medical Journals
33%
Medicare
33%
Mixed Methods Evaluation
33%
Multiphysics Object-oriented Simulation Environment (MOOSE)
9%
Online Pharmacies
5%
Ovarian Cancer
33%
Overall Survival Progression-free Survival
8%
Patient Benefit
33%
Patient Outcomes
37%
Patient Risk
33%
Patient-reported Outcomes
8%
Pediatric
33%
Potential Savings
16%
Preventative Medicine
5%
Pricing Model
5%
Reporting Guidelines
33%
Response Evaluation Criteria in Solid Tumors (RECIST)
5%
Risk Outcomes
33%
Risk-benefit
33%
Shipping Cost
5%
Spending Data
5%
Standardized Outcomes
8%
Trametinib
33%
Unit Price
5%
Yield Quality
5%
Pharmacology, Toxicology and Pharmaceutical Science
Atopic Dermatitis
33%
Clinical Research
8%
Clinical Trial
100%
Cross Sectional Study
33%
Dabrafenib
33%
Drug Analysis
33%
Drug Development
66%
Female Genital Tract Cancer
5%
Fluticasone Propionate
33%
Ovary Cancer
33%
Overall Survival
11%
Prescription Drug
33%
Progression Free Survival
11%
Trametinib
33%
Medicine and Dentistry
Awareness
11%
Clinical Study
6%
Clinical Trial
33%
Cross Sectional Study
9%
Decision Making
5%
Emergency Care
6%
Emergency Medicine
33%
Female Genital Tract Cancer
5%
Health Care Cost
33%
Logistic Regression Analysis
6%
Medicare
33%
Ovarian Cancer
33%
Overall Survival
11%
Patient Care
6%
Patient-Reported Outcome
11%
Prevalence
20%
Progression Free Survival
11%
Quality of Life
5%
Reproducibility
6%
Skin Disease
8%
